A short, 60 seconds read that summarises 4 handpicked articles that are worth reading about:
What is the price of a child’s life? The affordability of rare disease therapies
Correlating value with price in the US oncology market: Key learnings for manufacturers
Europe: IPCEI on health to promote development of gene and cell therapies
France: HAS extends early access authorisation to additional patients